NeoGenomics (NASDAQ: NEO) reported Q4 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $25 million versus the consensus estimate of $24.3 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.